UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 378

Sortiert nach

Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys ( Macaca fascicularis)

Bone (New York, N.Y.), 2001-02, Vol.28 (2), p.150-159

2001

Link zum Volltext

Verfügbarkeit prüfen

The Effects of a Comprehensive Reading Program on Reading Outcomes for Middle School Students With Disabilities

Journal of learning disabilities, 2017-03, Vol.50 (2), p.195-212

2017

Link zum Volltext

Verfügbarkeit prüfen

Six‐Month Daily Administration of Parathyroid Hormone and Parathyroid Hormone—Related Protein Peptides to Adult Ovariectomized Rats Markedly Enhances Bone Mass and Biomechanical Properties: A Comparison of Human Parathyroid Hormone 1–34, Parathyroid Hormone‐Related Protein 1–36, and SDZ‐Parathyroid Hormone 893

Journal of bone and mineral research, 2000-08, Vol.15 (8), p.1517-1525

2000

Link zum Volltext

Verfügbarkeit prüfen

Intermittently Administered Human Parathyroid Hormone(1–34) Treatment Increases Intracortical Bone Turnover and Porosity Without Reducing Bone Strength in the Humerus of Ovariectomized Cynomolgus Monkeys

Journal of bone and mineral research, 2001-01, Vol.16 (1), p.157-165

2001

Link zum Volltext

Verfügbarkeit prüfen

Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits

Bone (New York, N.Y.), 2001-05, Vol.28 (5), p.538-547

2001

Link zum Volltext

Verfügbarkeit prüfen

Anabolic Effects of Human Biosynthetic Parathyroid Hormone Fragment (1–34), LY333334, on Remodeling and Mechanical Properties of Cortical Bone in Rabbits

Journal of bone and mineral research, 1999-04, Vol.14 (4), p.536-545

1999

Link zum Volltext

Verfügbarkeit prüfen

Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys

The journal of clinical endocrinology and metabolism, 1999-10, Vol.84 (10), p.3757-3763

1999

Link zum Volltext

Verfügbarkeit prüfen

Bone Mineral and Collagen Quality in Humeri of Ovariectomized Cynomolgus Monkeys Given rhPTH(1–34) for 18 Months

Journal of bone and mineral research, 2003-04, Vol.18 (4), p.769-775

2003

Link zum Volltext

Verfügbarkeit prüfen

Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studies

British journal of pharmacology, 1991-03, Vol.102 (3), p.774-777

1991

Link zum Volltext

Verfügbarkeit prüfen

Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment

The Journal of pharmacology and experimental therapeutics, 2002-07, Vol.302 (1), p.304

2002

Link zum Volltext

Verfügbarkeit prüfen

Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studies

British journal of pharmacology, 1991-03, Vol.102 (3), p.769-773

1991

Link zum Volltext

Verfügbarkeit prüfen

Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34)

Calcified tissue international, 2000-06, Vol.66 (6), p.456-460

2000

Link zum Volltext

Verfügbarkeit prüfen

Stemming bone loss by suppressing apoptosis

The Journal of clinical investigation, 1999-08, Vol.104 (4), p.371-373

Hock, J M

1999

Link zum Volltext

Verfügbarkeit prüfen

Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats

Endocrinology (Philadelphia), 1988-06, Vol.122 (6), p.2899-2904

1988

Link zum Volltext

Verfügbarkeit prüfen

Growth hormone and parathyroid hormone stimulate intestinal calcium absorption in aged female rats

Endocrinology (Philadelphia), 1994-04, Vol.134 (4), p.1755-1760

1994

Link zum Volltext

Verfügbarkeit prüfen

The Addition of a Raloxifene Analog (LY117018) Allows for Reduced PTH(1–34) Dosing During Reversal of Osteopenia in Ovariectomized Rats

Journal of bone and mineral research, 1999-05, Vol.14 (5), p.675-679

1999

Link zum Volltext

Verfügbarkeit prüfen

Anabolic effect of parathyroid hormone is not modified by supplementation with insulinlike growth factor I (IGF-I) or growth hormone in aged female rats fed an energy-restricted or ad libitum diet

Bone (New York, N.Y.), 1995-02, Vol.16 (2), p.199-207

1995

Link zum Volltext

Verfügbarkeit prüfen

The effects of PTH (1-34) on bone structure and strength in ovariectomized monkeys

Advances in experimental medicine and biology, 2001, Vol.496, p.165

2001

Link zum Volltext

Verfügbarkeit prüfen

Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat

Bone (New York, N.Y.), 1999-05, Vol.24 (5), p.451-455

1999

Link zum Volltext

Verfügbarkeit prüfen

Autoantibodies directed to centromere protein F in a patient with BRCA1 gene mutation

BMC research notes, 2016-02, Vol.9 (81), p.84-84, Article 84

2016

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptors: selective ligands, partners, and distinctive pharmacology

Recent progress in hormone research, 2000, Vol.55, p.163

2000

Link zum Volltext

Verfügbarkeit prüfen

Analysis of differential gene expression in rat tibia after an osteogenic stimulus in vivo: Mechanical loading regulates osteopontin and myeloperoxidase

Journal of cellular biochemistry, 1998-03, Vol.68 (3), p.355-365

1998

Link zum Volltext

Verfügbarkeit prüfen

Igf-I and postnatal growth of weaver mutant mice

Endocrine, 2005-03, Vol.26 (2), p.117-126

2005

Link zum Volltext

Verfügbarkeit prüfen

What Makes Happy Doctors? Job Satisfaction of General Practitioners in Mecklenburg-Western Pomerania - a Representative Cross-sectional Study

Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)), 2015-12, Vol.77 (12), p.927

2015

Link zum Volltext

Verfügbarkeit prüfen

Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study

Genitourinary medicine, 1994-08, Vol.70 (4), p.240

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 378

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(355)
Mit Volltextzugriff
(311)

Publikationsform

Artikel
(378)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys ( Macaca fascicularis)

The Effects of a Comprehensive Reading Program on Reading Outcomes for Middle School Students With Disabilities

Intermittently Administered Human Parathyroid Hormone(1–34) Treatment Increases Intracortical Bone Turnover and Porosity Without Reducing Bone Strength in the Humerus of Ovariectomized Cynomolgus Monkeys

Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits

Anabolic Effects of Human Biosynthetic Parathyroid Hormone Fragment (1–34), LY333334, on Remodeling and Mechanical Properties of Cortical Bone in Rabbits

Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys

Bone Mineral and Collagen Quality in Humeri of Ovariectomized Cynomolgus Monkeys Given rhPTH(1–34) for 18 Months

Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studies

Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment

Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studies

Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34)

Stemming bone loss by suppressing apoptosis

Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats

Growth hormone and parathyroid hormone stimulate intestinal calcium absorption in aged female rats

The Addition of a Raloxifene Analog (LY117018) Allows for Reduced PTH(1–34) Dosing During Reversal of Osteopenia in Ovariectomized Rats

Anabolic effect of parathyroid hormone is not modified by supplementation with insulinlike growth factor I (IGF-I) or growth hormone in aged female rats fed an energy-restricted or ad libitum diet

The effects of PTH (1-34) on bone structure and strength in ovariectomized monkeys

Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat

Autoantibodies directed to centromere protein F in a patient with BRCA1 gene mutation

Estrogen receptors: selective ligands, partners, and distinctive pharmacology

Analysis of differential gene expression in rat tibia after an osteogenic stimulus in vivo: Mechanical loading regulates osteopontin and myeloperoxidase

Igf-I and postnatal growth of weaver mutant mice

What Makes Happy Doctors? Job Satisfaction of General Practitioners in Mecklenburg-Western Pomerania - a Representative Cross-sectional Study

Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study

Aktive Filter

Suchergebnisse filtern